The role of kappa free light chains in the diagnosis of multiple sclerosis

Dr. Irene Treviño Frenk, head of clinical research, Centro Médico ABC, explores the current landscape of multiple sclerosis diagnosis, the risks of a false or delayed detection, and how using kappa free light chains as a surrogate marker could help us to better manage and understand how the disease is evolving.